Skip to content

Opening book details…

About this Economics, Econometrics and Finance article

Breakthrough Therapy status – expedited FDA regulatory approval but what about the payers? by Macaulay, R.; Cost, P. is a Economics, Econometrics and Finance article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.

Author
Macaulay, R.; Cost, P.
Publisher
John Wiley and Sons; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1098-3015)
Published
2015
Field
Economics, Econometrics and Finance (Social Sciences)

More by Macaulay, R.; Cost, P.

Browse all works by Macaulay, R.; Cost, P.